within Pharmacolibrary.Drugs.ATC.C;

model C05BA03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.3333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 5.9999999999999995e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C05BA03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Heparin is an anticoagulant used to prevent and treat blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and during surgery or dialysis. It is an approved drug widely used in clinical practice for its rapid onset of action by parenteral routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for adult patients (general population) following intravenous bolus administration.</p><h4>References</h4><ol><li><p>Garcia, DA, et al., &amp; Samama, MM (2012). Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. <i>Chest</i> 141(2 Suppl) e24S–e43S. DOI:<a href=&quot;https://doi.org/10.1378/chest.11-2291&quot;>10.1378/chest.11-2291</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22315264/&quot;>https://pubmed.ncbi.nlm.nih.gov/22315264</a></p></li><li><p>Holbrook, A, et al., &amp; Guyatt, GH (2012). Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. <i>Chest</i> 141(2 Suppl) e152S–e184S. DOI:<a href=&quot;https://doi.org/10.1378/chest.11-2295&quot;>10.1378/chest.11-2295</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22315259/&quot;>https://pubmed.ncbi.nlm.nih.gov/22315259</a></p></li><li><p>Kandrotas, RJ (1992). Heparin pharmacokinetics and pharmacodynamics. <i>Clinical pharmacokinetics</i> 22(5) 359–374. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199222050-00003&quot;>10.2165/00003088-199222050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1505142/&quot;>https://pubmed.ncbi.nlm.nih.gov/1505142</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C05BA03;
